Filter
1197
Text search:
drug
resistance
management
program
Featured
126
408
Language
Document type
794
150
141
43
32
18
9
8
1
1
Countries
68
52
45
34
32
31
30
28
25
24
24
24
23
22
20
19
19
18
17
17
16
15
12
12
12
12
11
11
10
9
8
7
7
6
6
6
6
5
5
5
5
5
5
5
4
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
566
84
57
28
20
16
15
1
Toolboxes
186
134
127
50
33
32
21
21
19
18
16
12
8
7
6
6
4
4
4
4
3
1
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)
...
Promising Approaches to Combination HIV Prevention Programming in Concentrated Epidemics
AIDSTAR-One CASE STUDY SERIES May 2010
An Evidence-Based Treatment Guide for Clinicians
Government of Nepal has an obligation to ensure availability of affordable and high quality basic health care services to its population
In 2020, the COVID-19 pandemic impacted the world beyond imagination. To date, it has infected more than 135 million people, killed over 2.9 million people, and is projected to plunge up to 115 million people into extreme poverty.1 As countries have gone into lockdown, gender-based violence has incr
...
Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
recommended
This second edition of the Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline provides the most up to date technical guidance on mask use in community settings in the context of COVID-19.
In this edition, new information includes updated mask re
...
Results and Lessons Learned from CapacityPlus 2009-2015
TB in India 2017
recommended
Revised National TB Control Programme. Annual Status Report
Operational Guideline
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information
...
